https://medlineplus.gov/druginfo/meds/a624084.html
Obecabtagene Autoleucel Injection: MedlinePlus Drug Information
Obecabtagene Autoleucel Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus
obecabtagene autoleucelinjectionmedlineplusdruginformation
https://www.news-medical.net/news/20241202/New-study-explores-obecabtagene-autoleucel-for-adults-with-hard-to-treat-leukemia.aspx
New study explores obecabtagene autoleucel for adults with hard-to-treat leukemia
Dec 2, 2024 - FELIX study results reveal obe-cel's potential in relapsed B-cell ALL, achieving 77% remission with low severe toxicity, enhancing CAR T-cell therapy outcomes.
new studyobecabtagene autoleucelfor adults
https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL5095440
Compound: OBECABTAGENE AUTOLEUCEL (CHEMBL5095440) - ChEMBL
Report card for Compound OBECABTAGENE AUTOLEUCEL (CHEMBL5095440). Gene, AUCATZYL, AUTO-1, AUTO1, OBECABTAGENE AUTOLEUCEL.
obecabtagene autoleucelcompoundchembl
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-obecabtagene-autoleucel-adults-relapsed-or-refractory-b-cell-precursor-acute?
FDA approves obecabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute...
On November 8, 2024, the Food and Drug Administration approved obecabtagene autoleucel (Aucatzyl, Autolus Inc.), a CD19-directed genetically modified...